Xiaolan Hu

4.5k total citations
70 papers, 2.6k citations indexed

About

Xiaolan Hu is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Xiaolan Hu has authored 70 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 13 papers in Genetics and 9 papers in Oncology. Recurrent topics in Xiaolan Hu's work include Medicinal Plants and Bioactive Compounds (6 papers), Genetic Associations and Epidemiology (5 papers) and Flavonoids in Medical Research (4 papers). Xiaolan Hu is often cited by papers focused on Medicinal Plants and Bioactive Compounds (6 papers), Genetic Associations and Epidemiology (5 papers) and Flavonoids in Medical Research (4 papers). Xiaolan Hu collaborates with scholars based in China, United States and Macao. Xiaolan Hu's co-authors include Xiaoxia Peng, Daihua Yu, Zhenyu Tang, Xianqi Zhang, Lukas C. Amler, Carol O’Brien, Guy Cavet, Mark R. Lackner, Xiaowei Zhang and Kun Li and has published in prestigious journals such as Journal of Clinical Oncology, Environmental Science & Technology and Gastroenterology.

In The Last Decade

Xiaolan Hu

67 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolan Hu China 26 1.1k 492 277 245 228 70 2.6k
Vita Dolžan Slovenia 33 1.3k 1.1× 315 0.6× 241 0.9× 167 0.7× 255 1.1× 210 3.7k
Hong‐Hee Won South Korea 28 786 0.7× 362 0.7× 208 0.8× 225 0.9× 112 0.5× 135 2.5k
Alessandra Perna Italy 35 1.1k 1.0× 432 0.9× 519 1.9× 192 0.8× 236 1.0× 165 3.9k
Fabio Monzani Italy 44 768 0.7× 393 0.8× 407 1.5× 496 2.0× 252 1.1× 186 6.5k
James Blackshaw United Kingdom 4 957 0.9× 1.0k 2.1× 340 1.2× 321 1.3× 218 1.0× 5 2.7k
Ping Yang China 33 1.6k 1.4× 317 0.6× 294 1.1× 156 0.6× 86 0.4× 109 3.5k
W. Edward Visser Netherlands 46 891 0.8× 852 1.7× 307 1.1× 328 1.3× 477 2.1× 248 7.5k
Verena Zuber United Kingdom 31 784 0.7× 1.0k 2.1× 282 1.0× 394 1.6× 193 0.8× 77 2.9k
Stella Trompet Netherlands 34 589 0.5× 327 0.7× 602 2.2× 489 2.0× 234 1.0× 149 3.7k
Guixia Wang China 34 1.7k 1.5× 296 0.6× 705 2.5× 390 1.6× 284 1.2× 157 3.8k

Countries citing papers authored by Xiaolan Hu

Since Specialization
Citations

This map shows the geographic impact of Xiaolan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Hu more than expected).

Fields of papers citing papers by Xiaolan Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Hu. The network helps show where Xiaolan Hu may publish in the future.

Co-authorship network of co-authors of Xiaolan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolan Hu. A scholar is included among the top collaborators of Xiaolan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolan Hu. Xiaolan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Xiaolan, Jian‐Lin Wu, Quan He, Zhi‐Qi Xiong, & Na Li. (2024). Strategy for cysteine-targeting covalent inhibitors screening using in-house database based LC-MS/MS and drug repurposing. Journal of Pharmaceutical Analysis. 15(3). 101045–101045. 1 indexed citations
2.
Hu, Xiaolan, et al.. (2024). Serum osteocalcin levels are inversely associated with UACR in Chinese DKD patients: a meta-analysis of 20 clinical studies. Frontiers in Endocrinology. 15. 1514713–1514713.
3.
Zhang, Changhui, et al.. (2023). Aspergillus niger Fermentation Broth Promotes Maize Germination and Alleviates Low Phosphorus Stress. Microorganisms. 11(7). 1737–1737.
4.
Hu, Xiaolan, et al.. (2023). Less is more: A new perspective for toxicity of emerging contaminants by structures, protein adducts and proteomics. TrAC Trends in Analytical Chemistry. 167. 117289–117289. 12 indexed citations
5.
Hu, Xiaolan, et al.. (2023). An energy-based fatigue life estimation and optimization of an electric mining dump truck welded frame. Journal of the Brazilian Society of Mechanical Sciences and Engineering. 45(2). 4 indexed citations
6.
Hu, Xiaolan, Jian‐Lin Wu, Miao Wen, et al.. (2022). Covalent Protein Modification: An Unignorable Factor for Bisphenol A-Induced Hepatotoxicity. Environmental Science & Technology. 56(13). 9536–9545. 19 indexed citations
7.
Gong, Shilin, et al.. (2022). Dual roles of drug or its metabolite−protein conjugate: Cutting‐edge strategy of drug discovery using shotgun proteomics. Medicinal Research Reviews. 42(4). 1704–1734. 4 indexed citations
8.
Gong, Shilin, et al.. (2021). Quantification of Osimertinib and Metabolite–Protein Modification Reveals Its High Potency and Long Duration of Effects on Target Organs. Chemical Research in Toxicology. 34(11). 2309–2318. 7 indexed citations
9.
Fakhri, Sajad, Merve Tomaş, Esra Çapanoğlu, et al.. (2021). Antioxidant and anticancer potentials of edible flowers: where do we stand?. Critical Reviews in Food Science and Nutrition. 62(31). 8589–8645. 27 indexed citations
10.
11.
Wei, Xiaoli, et al.. (2020). Contribution of salidroside to the relieve of symptom and sign in the early acute stage of osteoarthritis in rat model. Journal of Ethnopharmacology. 259. 112883–112883. 14 indexed citations
12.
Li, Min�, et al.. (2016). Impact of Retinal Vein Occlusion on Stroke Incidence: A Meta‐Analysis. Journal of the American Heart Association. 5(12). 26 indexed citations
13.
Hu, Xiaolan, et al.. (2016). Efficacy of oxycodone for patient-controlled intravenous analgesia after hip arthroplasty in elderly patients. Zhonghua mazuixue zazhi. 36(10). 1229–1231. 1 indexed citations
14.
15.
Li, Min, Xiaolan Hu, Yingli Fan, et al.. (2016). Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis. Scientific Reports. 6(1). 19520–19520. 176 indexed citations
16.
Hu, Xiaolan, Eve H. Pickering, Sara Hall, et al.. (2011). Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment. Translational Psychiatry. 1(11). e54–e54. 30 indexed citations
17.
Hu, Xiaolan, et al.. (2010). Salidroside induces cell-cycle arrest and apoptosis in human breast cancer cells. Biochemical and Biophysical Research Communications. 398(1). 62–67. 77 indexed citations
18.
Zha, Jiping, Carol O’Brien, Heidi Savage, et al.. (2009). Molecular predictors of response to a humanized anti–insulin-like growth factor-I receptor monoclonal antibody in breast and colorectal cancer. Molecular Cancer Therapeutics. 8(8). 2110–2121. 66 indexed citations
19.
Hu, Xiaolan, Howard M. Stern, Lin Ge, et al.. (2009). Genetic Alterations and Oncogenic Pathways Associated with Breast Cancer Subtypes. Molecular Cancer Research. 7(4). 511–522. 177 indexed citations
20.
Wesoły, Joanna, Xiaolan Hu, Mohamed M. Thabet, et al.. (2006). The 620W allele is the PTPN22 genetic variant conferring susceptibility to RA in a Dutch population. Lara D. Veeken. 46(4). 617–621. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vita Dolžan Breakdown of academic impact, for papers by Hong‐Hee Won Breakdown of academic impact, for papers by Alessandra Perna Breakdown of academic impact, for papers by Fabio Monzani Breakdown of academic impact, for papers by James Blackshaw Breakdown of academic impact, for papers by Ping Yang Breakdown of academic impact, for papers by W. Edward Visser Breakdown of academic impact, for papers by Verena Zuber Breakdown of academic impact, for papers by Stella Trompet Breakdown of academic impact, for papers by Guixia Wang
Rankless by CCL
2026